Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells $693,163.80 in Stock

Summary by marketbeat.com
PTC Therapeutics, Inc. (NASDAQ:PTCT - Get Free Report) insider Neil Gregory Almstead sold 8,130 shares of the company's stock in a transaction that occurred on Friday, June 26th. The shares were sold at an average price of $85.26, for a total value of $693,163.80. Following the sale, the insider directly owned 60,137 shares of the company's stock, valued at approximately $5,127,280.62. This represents a 11.91% decrease in their ownership of the …

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news on Tuesday, June 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal